NEW YORK (GenomeWeb News) - The Broad Institute of Harvard and MIT is using Genedata's Screener software in its Molecular Libraries and Imaging Initiative, the Swiss company said today.
The Screener platform is used in automated high-throughput and high-content screening research aimed at studying small molecules for drug research.
"We're screening upwards of 50 assays and analyzing more than 20 million wells of screening data," Dave DeCaprio, associate director of the chemical biology platform at the Broad Institute, said in a statement. "Screener's interactive visualization capabilities enable our screeners to analyze their own data, eliminating the need for them to involve a separate informatics group."
The Molecular Libraries and Imaging Initiative is funded by the National Institutes of Health and involves nine institutions.
Financial terms of the agreement were not released.